Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.27 - $3.44 $46,228 - $70,055
-20,365 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$1.97 - $2.89 $11,288 - $16,559
5,730 Added 39.15%
20,365 $57,000
Q2 2020

Aug 17, 2020

BUY
$1.74 - $3.19 $25,464 - $46,685
14,635 New
14,635 $33,000
Q2 2018

Aug 14, 2018

SELL
$0.71 - $4.04 $7,964 - $45,320
-11,218 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$3.9 - $7.77 $5,070 - $10,101
-1,300 Reduced 10.39%
11,218 $67,000
Q3 2017

Nov 13, 2017

BUY
$3.83 - $6.07 $47,943 - $75,984
12,518
12,518 $75,000

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0

About vTv Therapeutics Inc.


  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.43B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.